Dawn Lee

Chief Scientific Officer


Dawn Lee is Chief Scientific Officer at BresMed.

Dawn is a passionate supporter of the move to more integrated statistical and health economic analyses and the use of appropriate software, such as R, to achieve this. She has experience in a number of disease areas and project types, and currently specializes in oncology modelling (in immuno-oncology in particular), early product assessment, health technology assessment (HTA) strategy, complex decision problems, models with complex statistical needs, end-to-end modelling solutions using R/R-Shiny and anything else “a bit weird and wonderful”. She is the originator of BresMed’s intRface™ a product created in R which integrates statistical analysis with a modeling framework to enable user- friendly, transparent and real-time investigation of alternative analyses.

Her role as Chief Scientific Officer focuses on achieving and maintaining BresMed’s position at the leading edge of health economics and outcomes research, identifying trends within the industry and new types of work and methods for BresMed.

Dawn holds an MMath degree from Bangor University as well as a MSc in health economics and decision modelling from ScHARR.